Nexalin Technology (NXL) Enterprise Value (2021 - 2026)

Nexalin Technology has reported Enterprise Value for 6 years, with the latest figure at -$2.7 million in Q1 2026.

• For the quarter ending Q1 2026, Enterprise Value fell 32.05% year-over-year to -$2.7 million; the trailing twelve-month figure through Mar 2026 stood at -$2.7 million (down 32.05% YoY), and the FY2025 full-year result was -$6.1 million, down 76.35% from the prior year.
• Enterprise Value for Q1 2026 stood at -$2.7 million, up from -$6.1 million in the prior quarter.
• The five-year high for Enterprise Value was -$848796.0 in Q2 2024, with the low at -$13.7 million in Q4 2022.
• Average Enterprise Value over 5 years is -$5.7 million, with a median of -$4.7 million recorded in 2023.
• Year-over-year, Enterprise Value slumped 1964.5% in 2022 and surged 90.49% in 2024.
• Tracing NXL's Enterprise Value over 5 years: stood at -$13.7 million in 2022, then soared by 65.33% to -$4.7 million in 2023, then increased by 26.53% to -$3.5 million in 2024, then tumbled by 76.35% to -$6.1 million in 2025, then surged by 55.87% to -$2.7 million in 2026.
• The last three Enterprise Value figures came in at -$2.7 million (Q1 2026), -$6.1 million (Q4 2025), and -$7.5 million (Q3 2025), per Business Quant data.

Peer Comparison